4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-17-002158
Director bought 2,222,222 shares at $2.70 ($5,999,999)
From the SEC's structured data for this filing
Trades in this filing
BROADWOOD PARTNERS, L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-02-15 | Purchase : show line 1 in the form | +2,222,222 | $2.70 | $5,999,999 | 27,119,254 | D |
| 2017-02-15 | Purchase : show line 2 in the form | +0 | 27,119,254 | I | ||
| Open-market purchases · 2,222,222 sh · avg $2.70 · $5,999,999 | ||||||
Loading xslF345X03/p7416080.xml…